Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000012306
JPRN-UMIN000012306
Completed
Phase 4

Observational study For Investigating the ability of Recuperation of work/ house work State with Tocilizumab (Actemra) SubCutaneous treatment in biologics-naive RA patients - FIRST ACT-SC study

EPS Corporation0 sites800 target enrollmentDecember 11, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsrheumatoid arthritis

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
rheumatoid arthritis
Sponsor
EPS Corporation
Enrollment
800
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 11, 2013
End Date
September 30, 2017
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •(1\)Patients who cannot use the drug in this study by contraindication. (2\)The principal investigator or co\-investigator has determined that the participation of the patient in the study would not be appropriate (3\)Patients who have been registered and examined in this study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 4
Observational study For Investigating the ability of Recuperation of work/ house work State with adalimumab treatment in RA patients in tohokurheumatoid arthritis
JPRN-UMIN000017429Tohoku uviversity hospital100
Completed
Not Applicable
An observational study to assess the ability of the thymine loading test to prospectively categorise patients with gastrointestinal or breast cancer who cannot tolerate fluoropyrimidine treatment.
ACTRN12617001109392niversity of Auckland166
Recruiting
Not Applicable
Prospective Study to investigate the ability of the Glutathione S- transferase Pi (GSTP1) methylation assay to assess response to chemotherapy in patients with metastatic hormone-refractory prostate cancerPatients with Metastatic hormone-refractory prostate cancerCancer - Prostate
ACTRN12607000077460Dr Lisa Horvath150
Completed
Not Applicable
An Observational Study to Investigate the Effectiveness of PK Guided Personalized Recombinant (r)FVIII Treatment in Patients with Hemophilia AHemophilia A
JPRN-UMIN000044800Takeda Pharmaceutical Company Limited.30
Not yet recruiting
Not Applicable
The exploratory observational study of the usefulness of pemafibrate in lipid management of primary dyslipidemiaPrimary dyslipidemia
JPRN-UMIN000052625Rinku General Medical Center10